Global Vaccines Market Growth at a CAGR of 6.32% from 2024 to 2032

The global Vaccines Market was valued at USD 55.82 billion in 2023 and is projected to reach USD 59.34 billion in 2024, with an estimated value of USD 96.90 billion by 2032. The market is expected to grow at a CAGR of 6.32% during the forecast period (2024–2032), driven by rising demand for immunization and advancements in vaccine technologies.

Vaccines Market Catalysts for Expansion

The growth of the vaccines market is influenced by several key factors including the increasing prevalence of infectious diseases, growing healthcare awareness, and advancements in vaccine development. Additionally, ongoing global health crises such as the COVID-19 pandemic have accelerated research and development activities, leading to the introduction of new vaccines. Moreover, increased vaccination programs by governments worldwide, especially in developing countries, have contributed to the expansion of the market. Rising healthcare expenditure and the development of innovative vaccine technologies, such as mRNA and viral vector vaccines, further support market growth.

Vaccine Market Segmentation

The vaccines market is segmented into several categories, each contributing to the overall market expansion.

By Technology

1. Conjugate Vaccines
2. Recombinant Vaccines
3. Inactivated and Subunit Vaccines
4. Live-attenuated Vaccines
5. Toxoid Vaccines
6. Viral Vector Vaccines
7. m-RNA Vaccines
8. Others

By Type

1. Monovalent Vaccines
2. Multivalent Vaccines

By Disease Indication

1. Pneumococcal Disease
2. Influenza
3. Combination Vaccines
4. HPV
5. Meningococcal Disease
6. Herpes Zoster
7. Rotavirus
8. MMR
9. Varicella
10. Hepatitis
11. DTP
12. Polio
13. Other Disease Indications

By Route of Administration

1. Intramuscular and Subcutaneous
2. Oral
3. Others (Neurology)

By End-User

1. Pediatric Vaccine
2. Adult Vaccine

Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/report/vaccines-market/request-sample

Top Performing Companies in the Vaccines Market

The vaccines market is highly competitive, with numerous top-performing companies actively contributing to the development of new vaccines and the expansion of the global market. Leading companies include:

1. Pfizer Inc.
2. GlaxoSmithKline plc
3. Merck and Co. Inc.
4. Sanofi
5. Pasteur Limited
6. CSL Limited
7. Emergent BioSolutions, Inc.
8. Johnson and Johnson Services, Inc.
9. AstraZeneca
10. Astellas Pharma Inc.
11. Serum Institute of India Pvt. Ltd.
12. Bavarian Nordic
13. Mitsubishi Tanabe Pharma Corporation
14. Daiichi Sankyo Company Limited
15. Panacea Biotec Ltd.
16. Biological E

These companies are at the forefront of technological innovations, strategic partnerships, and vaccine production to meet the growing demand for immunization globally.

Emerging Prospects in the Vaccines Market

The future of the vaccines market looks promising with emerging prospects such as the introduction of next-generation vaccines, including mRNA-based vaccines and personalized vaccines. Additionally, the development of vaccines targeting new diseases, along with booster shots for existing vaccines, is expected to drive the market growth further. Furthermore, increasing focus on vaccine affordability, access, and equity in low-income regions offers significant growth potential.

Industry Movements and Trends

Several movements in the industry are shaping the future of the vaccines market:

• Technological Advancements: The development of mRNA vaccines, viral vector vaccines, and other cutting-edge technologies is accelerating the pace of innovation in the vaccines market.
• Strategic Collaborations: Key players are forming strategic collaborations to enhance research and development capabilities, as well as to expand their global reach.
• Rising Demand for Combination Vaccines: Combination vaccines that protect against multiple diseases are gaining popularity due to their convenience and cost-effectiveness.
• Shift towards Adult Vaccines: With an aging global population, there is an increasing demand for adult vaccines, including flu vaccines and vaccines for diseases like shingles and pneumonia.

Geographic Analysis

The vaccines market exhibits notable growth across various regions. North America holds a significant market share due to the high adoption rate of vaccines and advanced healthcare infrastructure. Europe also contributes substantially to the market, driven by government vaccination programs and investments in healthcare. The Asia-Pacific region is witnessing rapid growth, fueled by increasing healthcare spending, expanding vaccination programs, and rising awareness in emerging markets. Latin America and the Middle East are also expected to experience substantial growth, owing to improvements in healthcare access and rising demand for vaccines.

Vaccines Market Data Insights

Straits Research’s in-depth analysis of the vaccines market provides key insights into the market's growth trajectory, segmentation, and future prospects. Our report is a comprehensive resource for understanding the vaccines market dynamics, including the factors driving growth, challenges, competitive landscape, and regional trends. This information is essential for stakeholders in the healthcare and pharmaceutical industries to make informed decisions and capitalize on emerging opportunities.

For more detailed insights and to request a customized report, please contact us.

Contact Us
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)